RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Britannia Life Sciences Stock

Britannia Life Sciences Debt 2024

Britannia Life Sciences Debt

5.96 CAD

Ticker

BLAB.CN

ISIN

CA11042D1087

WKN

A3DACS

In 2024, Britannia Life Sciences's total debt was 5.96 CAD, a 67.39% change from the 3.56 CAD total debt recorded in the previous year.

Britannia Life Sciences Aktienanalyse

What does Britannia Life Sciences do?

Britannia Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Britannia Life Sciences's Debt Structure

Britannia Life Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Britannia Life Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Britannia Life Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Britannia Life Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Britannia Life Sciences stock

What is the debt of Britannia Life Sciences this year?

Britannia Life Sciences has a debt level of 5.96 CAD this year.

What was the debt of Britannia Life Sciences compared to the previous year?

The debt of Britannia Life Sciences has increased by 67.39% compared to the previous year increased.

What are the consequences of high debt for investors in Britannia Life Sciences?

High debt can pose a risk for investors of Britannia Life Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Britannia Life Sciences?

Low debt means that Britannia Life Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Britannia Life Sciences affect the company?

An increase in debt of Britannia Life Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Britannia Life Sciences affect the company?

A reduction in debt of Britannia Life Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Britannia Life Sciences?

Some factors that can influence the debt of Britannia Life Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Britannia Life Sciences so important for investors?

The debts of Britannia Life Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Britannia Life Sciences take to change the debt?

To change the debt, Britannia Life Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Britannia Life Sciences pay?

Over the past 12 months, Britannia Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Britannia Life Sciences is expected to pay a dividend of 0 CAD.

What is the dividend yield of Britannia Life Sciences?

The current dividend yield of Britannia Life Sciences is .

When does Britannia Life Sciences pay dividends?

Britannia Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Britannia Life Sciences?

Britannia Life Sciences paid dividends every year for the past 0 years.

What is the dividend of Britannia Life Sciences?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Britannia Life Sciences located?

Britannia Life Sciences is assigned to the '-' sector.

Wann musste ich die Aktien von Britannia Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Britannia Life Sciences from 9/28/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Britannia Life Sciences pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Britannia Life Sciences in the year 2023?

In the year 2023, Britannia Life Sciences distributed 0 CAD as dividends.

In which currency does Britannia Life Sciences pay out the dividend?

The dividends of Britannia Life Sciences are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Britannia Life Sciences

Our stock analysis for Britannia Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Britannia Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.